Protosappanin A Protects DOX‐Induced Myocardial Injury and Cardiac Dysfunction by Targeting ACSL4/FTH1 Axis‐Dependent Ferroptosis
Advanced Science · 2024-09 · 11 (34)
DOI: 10.1002/advs.202310227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 10.07.2024. Verfasst von Jingxuan Cui und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China. Hauptthemen laut MEDLINE: Ferroptosis, Doxorubicin, Coenzyme A Ligases. Die Arbeit wurde bisher 124-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province.
Abstract (Originalsprache)
Doxorubicin (DOX) is an effective anticancer agent, but its clinical utility is constrained by dose‐dependent cardiotoxicity, partly due to cardiomyocyte ferroptosis. However, the progress of developing cardioprotective medications to counteract ferroptosis has encountered obstacles. Protosappanin A (PrA), an anti‐inflammatory compound derived from hematoxylin, shows potential against DOX‐induced cardiomyopathy (DIC). Here, it is reported that PrA alleviates myocardial damage and dysfunction by reducing DOX‐induced ferroptosis and maintaining mitochondrial homeostasis. Subsequently, the molecular target of PrA through proteome microarray, molecular docking, and dynamics simulation is identified. Mechanistically, PrA physically binds with ferroptosis‐related proteins acyl‐CoA synthetase long‐chain family member 4 (ACSL4) and ferritin heavy chain 1 (FTH1), ultimately inhibiting ACSL4 phosphorylation and subsequent phospholipid peroxidation, while also preventing FTH1 autophagic degradation and subsequent release of ferrous ions (Fe 2+ ) release. Given the critical role of ferroptosis in the pathogenesis of ischemia‐reperfusion (IR) injury, this further investigation posits that PrA can confer a protective effect against IR‐induced cardiac damage by inhibiting ferroptosis. Overall, a novel pharmacological inhibitor is unveiled that targets ferroptosis and uncover a dual‐regulated mechanism for cardiomyocyte ferroptosis in DIC, highlighting additional therapeutic options for chemodrug‐induced cardiotoxicity and ferroptosis‐triggered disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
- The Key Laboratory of Myocardial Ischemia, Harbin, 150086, China.
- State Key Laboratory of Frigid Zone Cardiovascular Disease, Harbin, 150086, China.
- Department of Cardiology Daping Hospital, The Third Military Medical, Chongqing, 400000, China.
- Department of Cardiology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
- Department of Thoracic Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China.
ORCID-Profile: Maomao Zhang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province
Zitieren
APA
Cui, J., Chen, Y., Yang, Q., Zhao, P., Yang, M., Wang, X., Mang, G., Yan, X., Wang, D., Tong, Z., Wang, P., Kong, Y., Wang, N., Wang, D., Dong, N., Liu, M., E, M., Zhang, M., & Yu, B. (2024). Protosappanin A Protects DOX‐Induced Myocardial Injury and Cardiac Dysfunction by Targeting ACSL4/FTH1 Axis‐Dependent Ferroptosis. Advanced Science, 11(34). https://doi.org/10.1002/advs.202310227
Vancouver
Cui J, Chen Y, Yang Q, Zhao P, Yang M, Wang X, et al. Protosappanin A Protects DOX‐Induced Myocardial Injury and Cardiac Dysfunction by Targeting ACSL4/FTH1 Axis‐Dependent Ferroptosis. Advanced Science. 2024;11(34). doi:10.1002/advs.202310227
BibTeX
@article{Cui2024,
author = {Cui, Jingxuan and Chen, Yujia and Yang, Qiannan and Zhao, Peng and Yang, Mian and Wang, Xiaoqi and Mang, Ge and Yan, Xiangyu and Wang, Di and Tong, Zhonghua and Wang, Penghe and Kong, Yingjin and Wang, Naixin and Wang, Dongni and Dong, Nana and Liu, Mingyang and E, Mingyan and Zhang, Maomao and Yu, Bo},
title = {Protosappanin A Protects DOX‐Induced Myocardial Injury and Cardiac Dysfunction by Targeting ACSL4/FTH1 Axis‐Dependent Ferroptosis},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {34},
doi = {10.1002/advs.202310227}
}
EUVIMED